Dr J Vijay Venkatraman is a Diabetologist, Drug Safety Physician, and Entrepreneur with 25 years of broad-based experience in Clinical Medicine and Drug Safety. He holds an MBA in Services Management and is the first Indian to be conferred the Fellowship of the Pharmaceutical Information & Pharmacovigilance Association (PIPA), UK.

As the Founder & CEO of Oviya MedSafe, a global Pharmacovigilance consulting and Drug Safety services organization incorporated in Coimbatore, India, and London, UK, Dr Vijay has been helping pharmaceutical and biotechnology companies fulfill compliance requirements since 2012.

He has served as the Regional Editor (India) for Global Forum, one of the official publications of the Drug Information Association (DIA), since April 2017. Previously, he held key leadership roles, including Chairman of the Indian Medical Association (IMA) Headquarters’ Standing Committee for Pharmacovigilance (2021), Executive Committee Member of the Indian Society for Clinical Research (ISCR), and Chair of ISCR’s Pharmacovigilance Council from 2015 to 2019.

A sought-after speaker, Dr Vijay has been invited to deliver lectures at international conferences and has contributed a chapter to a medical textbook. In addition to his academic contributions, he has authored numerous articles and whitepapers on pharmacovigilance, frequently shared his perspectives through media features and interviews, and actively promotes drug safety awareness among key stakeholders.

Dr Vijay has received multiple accolades, including the Leadership Excellence Award and the State Appreciation Award for Coordinating Academic Activities from the Indian Medical Association.